5,6-dihydroxy-2-indolylcarboxylic acid has been researched along with 5-(1,1-dioxido-1,2-thiazinan-2-yl)-n-(4-fluorobenzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide in 1 studies
| Studies (5,6-dihydroxy-2-indolylcarboxylic acid) | Trials (5,6-dihydroxy-2-indolylcarboxylic acid) | Recent Studies (post-2010) (5,6-dihydroxy-2-indolylcarboxylic acid) | Studies (5-(1,1-dioxido-1,2-thiazinan-2-yl)-n-(4-fluorobenzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide) | Trials (5-(1,1-dioxido-1,2-thiazinan-2-yl)-n-(4-fluorobenzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide) | Recent Studies (post-2010) (5-(1,1-dioxido-1,2-thiazinan-2-yl)-n-(4-fluorobenzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide) |
|---|---|---|---|---|---|
| 99 | 0 | 20 | 21 | 0 | 5 |
| Protein | Taxonomy | 5,6-dihydroxy-2-indolylcarboxylic acid (IC50) | 5-(1,1-dioxido-1,2-thiazinan-2-yl)-n-(4-fluorobenzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide (IC50) |
|---|---|---|---|
| Gag-Pol polyprotein | HIV-1 M:B_HXB2R | 0.0285 | |
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 0.005 | |
| Integrase | Human immunodeficiency virus 1 | 0.5167 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dubey, S; Lavania, H; Satyanarayana, YD | 1 |
1 review(s) available for 5,6-dihydroxy-2-indolylcarboxylic acid and 5-(1,1-dioxido-1,2-thiazinan-2-yl)-n-(4-fluorobenzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide
| Article | Year |
|---|---|
Development of integrase inhibitors for treatment of AIDS: an overview.
Topics: Acquired Immunodeficiency Syndrome; Cells, Cultured; HIV Integrase Inhibitors; Humans; Virus Replication | 2007 |